본문 바로가기
KERD
논문KCI 등재

Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류의학일반

초록

Purpose: Eph receptors are differentially expressed in numerous malignant tumors. This study intended to analyze the roles ofEphB receptors (EphB2, B3, and B4) in urinary bladder cancer. Materials and Methods: Tissue microarray-based immunohistochemical analysis was used to investigate the expression patternsof EphB2, EphB3, and EphB4 in 154 bladder cancer specimens. Immunohistochemical staining was conducted examining theextent of stained cells and staining intensity. EphB was considered to be highly expressed when the intensity of staining was morethan moderate in >25% of cells in the tissue section. Small interfering RNA (siRNA) was used to knock down EphB expression inbladder cancer cell lines (T24, 5637) to determine the effects of EphB on tumor cell invasion, proliferation, and migration. Results: EphB receptors (B2, B3, and B4) were detected in 40.9% (EphB2, 63/154), 71.4% (EphB3, 110/154), and 53.2% (EphB4,82/154) of bladder cancer specimens. Low expression of EphB2, B3, and B4 receptors were significantly associated with higher tumorgrade (EphB2, p<0.001; EphB3, p=0.032; EphB4, p<0.001) and muscular invasion (EphB2, p=0.002; EphB3, p=0.009; EphB4,p<0.001). No obvious correlation was observed with other clinicopathological variables, such as age, sex, recurrence, lymph nodeinvolvement, metastasis, and overall survival. Inactivation of EphB receptors by siRNA transfection increased cell viability, tumorcell invasion, proliferation, and migration in comparison with untransfected cancer cells. Conclusion: Low expression of EphB receptors (B2, B3, and B4) can be a predictive marker for muscular invasion of bladder cancer.

Abstract

Purpose: Eph receptors are differentially expressed in numerous malignant tumors. This study intended to analyze the roles ofEphB receptors (EphB2, B3, and B4) in urinary bladder cancer. Materials and Methods: Tissue microarray-based immunohistochemical analysis was used to investigate the expression patternsof EphB2, EphB3, and EphB4 in 154 bladder cancer specimens. Immunohistochemical staining was conducted examining theextent of stained cells and staining intensity. EphB was considered to be highly expressed when the intensity of staining was morethan moderate in >25% of cells in the tissue section. Small interfering RNA (siRNA) was used to knock down EphB expression inbladder cancer cell lines (T24, 5637) to determine the effects of EphB on tumor cell invasion, proliferation, and migration. Results: EphB receptors (B2, B3, and B4) were detected in 40.9% (EphB2, 63/154), 71.4% (EphB3, 110/154), and 53.2% (EphB4,82/154) of bladder cancer specimens. Low expression of EphB2, B3, and B4 receptors were significantly associated with higher tumorgrade (EphB2, p<0.001; EphB3, p=0.032; EphB4, p<0.001) and muscular invasion (EphB2, p=0.002; EphB3, p=0.009; EphB4,p<0.001). No obvious correlation was observed with other clinicopathological variables, such as age, sex, recurrence, lymph nodeinvolvement, metastasis, and overall survival. Inactivation of EphB receptors by siRNA transfection increased cell viability, tumorcell invasion, proliferation, and migration in comparison with untransfected cancer cells. Conclusion: Low expression of EphB receptors (B2, B3, and B4) can be a predictive marker for muscular invasion of bladder cancer.

참고문헌 (38)

  1. Siegel R, "Cancer statistics, 2014", CA Cancer J Clin, 64, pp.9~29 (2014)
  2. Cookson MS, "The treated natural history of high risk superficial bladder cancer : 15-year outcome", J Urol, 158, pp.62~67 (1997)
  3. Mitra AP, "Molecular pathways in invasive bladder cancer : new insights into mechanisms, progression, and target identification", J Clin Oncol, 24, pp.5552~5564 (2006)
  4. Klein R, "Eph", ephrin signalling during development, 2012, pp.139, 4105~4109
  5. Pasquale EB, "Eph receptors and ephrins in cancer : bidirectional signalling and beyond", Nat Rev Cancer, 10, pp.165~180 (2010)
  6. Takai N, "Expression of receptor tyrosine kinase EphB4 and its ligand ephrin-B2 is associated with malignant potential in endometrial cancer", Oncol Rep, 8, pp.567~573 (2001)
  7. Varelias A, "Human osteosarcoma expresses specific ephrin profiles : implications for tumorigenicity and prognosis", Cancer, 95, pp.862~869 (2002)
  8. Brantley-Sieders DM, "Eph", ephrin profiling in human breast cancer reveals significant associations between expression level and clinical outcome, 2011, pp.6, e24426~
  9. Xia G, "EphB4receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival", Oncogene, 25, pp.769~780 (2006)
  10. Kumar SR, "Receptor tyrosine kinase EphB4 is a survival factor in breast cancer", Am J Pathol, 169, pp.279~293 (2006)
  11. Xia G, "EphB4 expression and biological significance in prostate cancer", Cancer Res, 65, pp.4623~4632 (2005)
  12. Kumar SR, "The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome", Br J Cancer, 96, pp.1083~1091 (2007)
  13. Masood R, "EphB4 provides survival advantage to squamous cell carcinoma of the head and neck", Int J Cancer, 119, pp.1236~1248 (2006)
  14. Fang WB, "A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis", Oncogene, 24, pp.7859~7868 (2005)
  15. Guo DL, "Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours", Carcinogenesis, 27, pp.454~464 (2006)
  16. Li X, "The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder", PLoS One, 9, pp.e105326~ (2014)
  17. Birgbauer E, "Kinase independent function of EphB receptors in retinal axon pathfinding to the optic disc from dorsal but not ventral retina", Development, 127, pp.1231~1241 (2000)
  18. Batlle E, "EphB receptor activity suppresses colorectal cancer progression", Nature, 435, pp.1126~1130 (2005)
  19. Ji XD, "EphB3 is overexpressed in non-small-cell lung cancer and promotes tumor metastasis by enhancing cell survival and migration", Cancer Res, 71, pp.1156~1166 (2011)
  20. Livak KJ, "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T))Method", Methods, 25, pp.402~408 (2001)
  21. Sylvester RJ, "Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables : a combined analysis of 2596 patients from seven EORTC trials", Eur Urol, 49, pp.466~477 (2006)
  22. Pasquale EB, "Eph receptor signalling casts a wide net on cell behaviour", Nat Rev Mol Cell Biol, 6, pp.462~475 (2005)
  23. Janes PW, "Eph", ephrin signalling and function in oncogenesis : lessons from embryonic development, 2008, pp.8, 473~479
  24. Kiyokawa E, "Overexpression of ERK, an EPH family receptor protein tyrosine kinase, in various human tumors", Cancer Res, 54, pp.3645~3650 (1994)
  25. Berclaz G, "Loss of EphB4 receptor tyrosine kinase protein expression during carcinogenesis of the human breast", Oncol Rep, 9, pp.985~989 (2002)
  26. Oshima T, "Overexpression of EphA4 gene and reduced expression of EphB2 gene correlates with liver metastasis in colorectal cancer", Int J Oncol, 33, pp.573~577 (2008)
  27. Yu G, "Reduced expression of EphB2 is significantly associated with nodal metastasis in Chinese patients with gastric cancer", J Cancer Res Clin Oncol, 137, pp.73~80 (2011)
  28. Krull CE, "Interactions of Eph-related receptors and ligands confer rostrocaudal pattern to trunk neural crest migration", Curr Biol, 7, pp.571~580 (1997)
  29. Chiu ST, "Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells", Carcinogenesis, 30, pp.1475~1486 (2009)
  30. Gao W, "EphB3 protein is associated with histological grade and FIGO stage in ovarian serous carcinomas", APMIS, 125, pp.122~127 (2017)
  31. Noren NK, "Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth", Proc Natl Acad Sci U S A, 101, pp.5583~5588 (2004)
  32. Hu F, "Down-regulation of EphB4phosphorylation is necessary for esophageal squamous cell carcinoma tumorigenecity", Tumour Biol, 35, pp.7225~7232 (2014)
  33. Rutkowski R, "Evidence for a dual function of EphB4 as tumor promoter and suppressor regulated by the absence or presence of the ephrin-B2 ligand", Int J Cancer, 131, pp.E614~24 (2012)
  34. Yoshida T, "Three-dimensional organoid culture reveals involvement of Wnt", β-catenin pathway in proliferation of bladder cancer cells, 2018, pp.9, 11060~11070
  35. Ahmad I, "β-catenin activation synergizes with PTEN loss to cause bladder cancer formation", Oncogene, 30, pp.178~189 (2011)
  36. Clevers H, "EphB", EphrinB receptors and Wnt signaling in colorectal cancer, 2006, pp.66, 2~5
  37. Jing Y, "Activated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transition", Cancer Lett, 348, pp.135~145 (2014)
  38. Noren NK, "The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway", Nat Cell Biol, 8, pp.815~825 (2006)

관련 논문AI추천

Prognostic Significance of EPHB2 Expression in Colorectal Cancer Progression강경훈, 김혜성, 배정모, 장보근, 장원영대한병리학회 · Journal of Pathology and Translational Medicine2018 · 제52권 제5호The Expression of Pigment Epithelium-Derived Factor in Bladder Transitional Cell Carcinoma김성우, 이경섭, 장태정대한병리학회 · Journal of Pathology and Translational Medicine2012 · 제46권 제3호The Expression Pattern of Annexin A1 in Urinary Bladder Urothelial Carcinoma and Its Clinicopathologic Significance고숙경, 김은경, 이원미, 이호정, 주종은, 최승규, 홍영옥대한병리학회 · Journal of Pathology and Translational Medicine2011 · 제45권 제1호Ligand-Independent Epidermal Growth Factor Receptor Overexpression Correlates with Poor Prognosis in Colorectal Cancer강성범, 곽윤진, 김덕우, 남수경, 서안나, 오흥권, 윤수미, 이혜승대한암학회 · Cancer Research and Treatment2018 · 제50권 제4호Parafibromin Staining Characteristics in Urothelial Carcinomas and Relationship with Prognostic ParametersBanu Sarsik Kumbaraci, Banu Yaman, Hakan Ozturk, Serap Karaarslan대한병리학회 · Journal of Pathology and Translational Medicine2015 · 제49권 제5호The EGFR Protein Expression and the Gene Copy Number Changes in Renal Cell Carcinomas김애리, 김영식, 김인선, 안정석, 이상호, Genitourinary Pathology Study Group대한병리학회 · Journal of Pathology and Translational Medicine2009 · 제43권 제5호

이 간행물의 다른 논문 (9건)